Manipal Health IPO Day 2: Issue Subscribed Only 15% So Far, GMP Fall; Should You Apply? Check Recommendatio
The IPO of Manipal Health Enterprises received a lukewarm response on its second day of subscription. With only 15% of the issue subscribed, the listing price is likely to be at or below the issue price. The grey market premium has also declined, signaling reduced investor confidence.
This slow uptake suggests retail investors are cautious about the valuation and the competitive landscape of the healthcare sector. For investors, the key takeaway is that the stock may not open at a premium on listing. It is crucial to evaluate the company's financials and future growth prospects independently before deciding to apply.
Key takeaways
- Category: IPO.
- AI reads the tone as negative (potentially bearish) for the stock.
Why it matters
A routine update. The tone is negative — watch for downside reaction. Use the price and stock snapshot to gauge how the market is responding.









